Antifibrinolytics in the treatment of traumatic brain injury

Traumatic brain injury (TBI) is a leading cause of trauma-related deaths, and pharmacologic interventions to limit intracranial bleeding should improve outcomes. Tranexamic acid reduces mortality in injured patients with major systemic bleeding, but the effects of antifibrinolytic drugs on outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Schober, Patrick, Loer, Stephan A., Schwarte, Lothar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
NEUROANESTHESIA: Edited by Anthony R. Absalom
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594127/
https://www.ncbi.nlm.nih.gov/pubmed/35900731
http://dx.doi.org/10.1097/ACO.0000000000001171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594127/
https://www.ncbi.nlm.nih.gov/pubmed/35900731
http://dx.doi.org/10.1097/ACO.0000000000001171

Ejemplares similares